Oxidative Stress and Huntington’s Disease: The Good, the Bad, and the Ugly

A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Grynkiewicz, G., Poenie, M., & Tsien, R. Y. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83641-4 · Cited by 21,722 · see citing works

Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity

Polazzi, E., Mengoni, I., Caprini, M., Peña‐Altamira, E., Kurtys, E., & Monti, B. (2012) · Neurosignals · doi:10.1159/000337115 · Cited by 9,023 · see citing works

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes

MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366 · see citing works

Oxidative Stress and Antioxidant Defense

Birben, E., Şahiner, Ü. M., Saçkesen, C., ERZURUM, S. C., & Kalaycı, Ö. (2012) · World Allergy Organization Journal · doi:10.1097/wox.0b013e3182439613 · Cited by 4,960 · see citing works

ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis

D'Autréaux, B., & Toledano, M. B. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2256 · Cited by 3,642 · see citing works

Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain

Itoh, K., Wakabayashi, N., Katoh, Y., Ishii, T., Igarashi, K., Engel, J. D., & Yamamoto, M. (1999) · Genes & Development · doi:10.1101/gad.13.1.76 · Cited by 3,634 · see citing works

Multiple Wearable Sensors in Parkinson and Huntington Disease Individuals: A Pilot Study in Clinic and at Home

Adams, J., Dinesh, K., Xiong, M., Tarolli, C. G., Sharma, S., Sheth, N., Aranyosi, A. J., Zhu, W. Y., Goldenthal, S. B., Biglan, K., et al. (2017) · Digital Biomarkers · doi:10.1159/000479018 · Cited by 3,190 · see citing works

Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1

Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160 · see citing works

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group.

Shah, M. A., Datson, N. A., Srinidhi, L., Stanton, V. P., MacDonald, M. E., Allard, M. W., Youngman, S., Am, F., Mott, R., Draths, K., et al. (1993) · Cell · Cited by 3,055 · see citing works

The role of antioxidants in the chemistry of oxidative stress: A review

Pisoschi, A. M., & Pop, A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.04.040 · Cited by 2,844 · see citing works

Calcium homeostasis in intact lymphocytes: cytoplasmic free calcium monitored with a new, intracellularly trapped fluorescent indicator.

Tsien, R. Y., Pozzan, T., & RINK, T. J. (1982) · The Journal of Cell Biology · doi:10.1083/jcb.94.2.325 · Cited by 2,251 · see citing works

Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2

Kobayashi, A., Kang, M.-I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., & Yamamoto, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.7130-7139.2004 · Cited by 2,224 · see citing works

H ₂ O ₂ , a Necessary Evil for Cell Signaling

Rhee, S. G. (2006) · Science · doi:10.1126/science.1130481 · Cited by 2,160 · see citing works

Metabolic control through the PGC-1 family of transcription coactivators

Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130 · cited 1× · see citing works

Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord

Kigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., & Popovich, P. G. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3257-09.2009 · Cited by 2,130 · see citing works

Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants

Dinkova-Kostova, A. T., Holtzclaw, W. D., Cole, R. N., Itoh, K., Wakabayashi, N., Katoh, Y., Yamamoto, M., & Talalay, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398899 · Cited by 1,947 · see citing works

Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations

Kalyanaraman, B., Darley-Usmar, V. M., Davies, K. J. A., Dennery, P. A., Forman, H. J., Grisham, M. B., Mann, G. E., Moore, K. P., Roberts, L. J., & Ischiropoulos, H. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.030 · Cited by 1,795 · see citing works

Huntington's disease: from molecular pathogenesis to clinical treatment

Ross, C. A., & Tabrizi, S. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70245-3 · Cited by 1,751 · see citing works

Nrf2–Keap1 defines a physiologically important stress response mechanism

Motohashi, H., & Yamamoto, M. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.09.003 · Cited by 1,725 · see citing works

Biomarkers of Oxidative Damage in Human Disease

Dalle-Donne, I., Rossi, R., Colombo, R., Giustarini, D., & Milzani, A. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.061408 · Cited by 1,703 · see citing works

Tlr signalling augments macrophage bactericidal activity through mitochondrial ros

West, A. P., Brodsky, I. E., Rahner, C., Woo, D. K., Erdjument-Bromage, H., Tempst, P., Walsh, M. C., Choi, Y., Shadel, G. S., & Ghosh, S. (2011) · Nature · doi:10.1038/nature09973 · Cited by 1,659 · see citing works

The ATM protein kinase: regulating the cellular response to genotoxic stress, and more

Shiloh, Y., & Ziv, Y. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3546 · Cited by 1,649 · see citing works

Nrf2:INrf2 (Keap1) signaling in oxidative stress

Kaspar, J. W., Niture, S. K., & Jaiswal, A. K. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.07.035 · Cited by 1,646 · see citing works

REPAIR OF OXIDATIVE DAMAGE TO DNA: Enzymology and Biology

Demple, B., & Harrison, L. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.004411 · Cited by 1,495 · see citing works

The role of oxidative stress in neurodegenerative diseases

Kim, G. H., Kim, J. E., Rhie, S. J., & Yoon, S. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.325 · Cited by 1,355 · see citing works

Mitochondria are required for antigen-specific t cell activation through reactive oxygen species signaling

Sena, L. A., Li, S., Jairaman, A., Prakriya, M., Ezponda, T., Hildeman, D. A., Wang, C.-R., Schumacker, P. T., Licht, J. D., Perlman, H., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.10.020 · Cited by 1,338 · see citing works

Huntington Disease

Vonsattel, J. P., & DiFiglia, M. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199805000-00001 · Cited by 1,305 · see citing works

Genetically encoded fluorescent indicator for intracellular hydrogen peroxide

Belousov, V. V., Fradkov, A. F., Lukyanov, K. A., Staroverov, D. B., Shakhbazov, K., Terskikh, A. V., & Lukyanov, S. (2006) · Nature Methods · doi:10.1038/nmeth866 · Cited by 1,260 · see citing works

M1 and M2 Macrophages: Oracles of Health and Disease

Mills, C. D. (2012) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v32.i6.10 · Cited by 1,145 · see citing works

SIRT1 Functionally Interacts with the Metabolic Regulator and Transcriptional Coactivator PGC-1α

Nemoto, S., Fergusson, M. M., & Finkel, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501485200 · Cited by 1,047 · see citing works

Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

Beal, M. F., Brouillet, E., Jenkins, B. G., Ferrante, R. J., Kowall, N. W., Miller, J., Storey, E., Srivastava, R., Rosen, B. R., & Hyman, B. T. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04181.1993 · Cited by 1,026 · see citing works

The Keap1-BTB Protein Is an Adaptor That Bridges Nrf2 to a Cul3-Based E3 Ligase: Oxidative Stress Sensing by a Cul3-Keap1 Ligase

Cullinan, S. B., Gordan, J. D., Jin, J., Harper, J. W., & Diehl, J. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8477-8486.2004 · Cited by 986 · see citing works

Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor

Lee, S.-R., Kwon, K.-S., Kim, S.-R., & Rhee, S. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15366 · Cited by 969 · see citing works

Repeat instability: mechanisms of dynamic mutations

Pearson, C. E., Edamura, K. N., & Cleary, J. D. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1689 · Cited by 924 · cited 1× · see citing works

Clinical Relevance of Biomarkers of Oxidative Stress

Frijhoff, J., Winyard, P. G., Žarković, N., Davies, S. S., Stocker, R., Cheng, D., Knight, A. R., Taylor, E., Oettrich, J., Ruskovska, T., et al. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6317 · Cited by 918 · see citing works

Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia

Browne, S. E., Bowling, A. C., Macgarvey, U., Baik, M. J., Berger, S. C., Muquit, M. M. K., Bird, E. D., & Beal, M. F. (1997) · Annals of Neurology · doi:10.1002/ana.410410514 · Cited by 885 · see citing works

The role of mitochondria in reactive oxygen species metabolism and signaling

Starkov, A. A. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.015 · Cited by 846 · see citing works

A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length

Langbehn, D. R., Brinkman, R. R., Falush, D., Paulsen, J. S., Hayden, M. R., & on behalf of an International Huntington's Disease Collaborative Group (2004) · Clinical Genetics · doi:10.1111/j.1399-0004.2004.00241.x · Cited by 820 · see citing works

Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes

Zuccato, C., Tartari, M., Crotti, A., Goffredo, D., Valenza, M., Conti, L., Cataudella, T., Leavitt, B. R., Hayden, M. R., Timmusk, T., et al. (2003) · Nature Genetics · doi:10.1038/ng1219 · Cited by 814 · see citing works

Redox-based regulation of signal transduction: principles, pitfalls, and promises

Janssen-Heininger, Y. M. W., Mossman, B. T., Heintz, N. H., Forman, H. J., Kalyanaraman, B., Finkel, T., Stamler, J. S., Rhee, S. G., & van der Vliet, A. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.011 · Cited by 784 · see citing works

Mitochondrial defect in Huntington's disease caudate nucleus

Gu, M., Gash, M. T., Mann, V. M., Javoy‐Agid, F., Cooper, J. M., & Schapira, A. H. V. (1996) · Annals of Neurology · doi:10.1002/ana.410390317 · Cited by 758 · see citing works

Decreased expression of striatal signaling genes in a mouse model of Huntington's disease

Luthi‐Carter, R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.9.1259 · Cited by 723 · see citing works

Repeat instability : mechanisms of dynamic mutations

Pearson, C. E. (2005) · Medical Entomology and Zoology · Cited by 711 · see citing works

Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease

Dunah, A. W., Jeong, H., Griffin, A. M., Kim, Y., Standaert, D. G., Hersch, S. M., Mouradian, M. M., Young, A. B., Tanese, N., & Krainc, D. (2002) · Science · doi:10.1126/science.1072613 · Cited by 708 · see citing works

Chop deletion reduces oxidative stress, improves β cell function, and promotes cell survival in multiple mouse models of diabetes

Song, B., Scheuner, D. L., Ron, D., Pennathur, S., & Kaufman, R. J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34587 · Cited by 693 · see citing works

Biological Activities of Reactive Oxygen and Nitrogen Species: Oxidative Stress versus Signal Transduction

Weidinger, A., & Kozlov, A. V. (2015) · Biomolecules · doi:10.3390/biom5020472 · Cited by 648 · see citing works

Hydrogen Peroxide: A Key Messenger That Modulates Protein Phosphorylation Through Cysteine Oxidation

Rhee, S. G., Bae, Y. S., Lee, S.-R., & Kwon, J. (2000) · Science s STKE · doi:10.1126/stke.2000.53.pe1 · Cited by 646 · see citing works

Reversible oxidation and inactivation of the tumor suppressor PTEN in cells stimulated with peptide growth factors

Kwon, J., Lee, S.-R., Yang, K.-S., Ahn, Y., Kim, Y. J., Stadtman, E. R., & Rhee, S. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407396101 · Cited by 631 · see citing works

Regulation of Corepressor Function by Nuclear NADH

Zhang, Q., Piston, D. W., & Goodman, R. H. (2002) · Science · doi:10.1126/science.1069300 · Cited by 620 · see citing works

Full-Length Human Mutant Huntingtin with a Stable Polyglutamine Repeat Can Elicit Progressive and Selective Neuropathogenesis in BACHD Mice

Gray, M., Shirasaki, D., Cepeda, C., André, V., Wilburn, B., Lu, X.-H., Tao, J., Yamazaki, I., Li, S.-H., Sun, Y. E., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0857-08.2008 · Cited by 616 · see citing works

Sir2 Regulates Skeletal Muscle Differentiation as a Potential Sensor of the Redox State

Fulco, M., Schiltz, R. L., Iezzi, S., King, M. T., Zhao, P., Kashiwaya, Y., Hoffman, E. P., Veech, R. L., & Sartorelli, V. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00226-0 · Cited by 590 · see citing works

Oxidative Stress and Neurodegenerative Disorders

Li, J., Wuliji, O., Li, W., Jiang, Z.-G., & Ghanbari, H. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141224438 · Cited by 511 · see citing works

Oxidative stress in Huntington’s disease

Browne, S. E., Ferrante, R. J., & Beal, M. F. (1999) · Brain Pathology · doi:10.1111/j.1750-3639.1999.tb00216.x · Cited by 508 · see citing works

Biological metals and metal-targeting compounds in major neurodegenerative diseases

Barnham, K. J., & Bush, A. I. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00138a · Cited by 497 · see citing works

Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin

Wyttenbach, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.9.1137 · Cited by 494 · see citing works

Protein Disulfide Isomerase Acts as a Redox-Dependent Chaperone to Unfold Cholera Toxin

Tsai, B., Rodighiero, C., Lencer, W. I., & Rapoport, T. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00289-6 · Cited by 484 · see citing works

p53 Mediates Cellular Dysfunction and Behavioral Abnormalities in Huntington’s Disease

Bae, B.-I., Xu, H., Igarashi, S., Fujimuro, M., Agrawal, N., Taya, Y., Hayward, S. D., Moran, T. H., Montell, C., Ross, C. A., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.005 · Cited by 480 · see citing works

Oxidative Stress and Its Significant Roles in Neurodegenerative Diseases and Cancer

Thanan, R., Oikawa, S., Hiraku, Y., Ohnishi, S., Ma, N., Pinlaor, S., Yongvanit, P., Kawanishi, S., & Murata, M. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms16010193 · Cited by 459 · see citing works

2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP–dependent metabolic regulation of chromatin structure

Garriga-Canut, M., Schoenike, B. A., Qazi, R., Bergendahl, K., Daley, T. J., Pfender, R. M., Morrison, J. F., Ockuly, J. C., Stafstrom, C. E., Sutula, T. P., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1791 · Cited by 446 · see citing works

OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells

Kovtun, I. V., Liu, Y., Bjoras, M., Klungland, A., Wilson, S. H., & McMurray, C. T. (2007) · Nature · doi:10.1038/nature05778 · Cited by 433 · see citing works

Huntingtin functions as a scaffold for selective macroautophagy

Rui, Y.-N., Xu, Z., Patel, B., Chen, Z., Chen, D., Tito, A., David, G., Sun, Y., Stimming, E. F., Bellen, H. J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3101 · Cited by 423 · see citing works

The challenges of using fluorescent probes to detect and quantify specific reactive oxygen species in living cells

Winterbourn, C. C. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.05.004 · Cited by 420 · see citing works

Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice

MANLEY, K. M., Shirley, T. L., Flaherty, L. A., & Messer, A. C. (1999) · Nature Genetics · doi:10.1038/70598 · Cited by 415 · see citing works

Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington’s disease

Paul, B. D., Sbodio, J. I., Xu, R., Vandiver, M. S., Cha, J. Y., Snowman, A. M., & Snyder, S. H. (2014) · Nature · doi:10.1038/nature13136 · Cited by 407 · see citing works

Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription

Shimohata, T., Nakajima, T., Yamada, M., Uchida, C., Onodera, O., Naruse, S., Kimura, T., Koide, R., Nozaki, K., Sano, Y., et al. (2000) · Nature Genetics · doi:10.1038/79139 · Cited by 393 · see citing works

Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid

Brouillet, E., Jenkins, B. G., Hyman, B. T., Ferrante, R. J., Kowall, N. W., Srivastava, R., Roy, D. S., Rosen, B. R., & Beal, M. F. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb05859.x · Cited by 367 · see citing works

S-Nitrosylation of mitochondrial caspases

Mannick, J. B., Schonhoff, C. M., Papeta, N., Ghafourifar, P., Szibor, M., Fang, K., & Gaston, B. M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200104008 · Cited by 363 · see citing works

In situ evidence for DNA fragmentation in Huntingtonʼs disease striatum and Alzheimerʼs disease temporal lobes

Dragunow, M., Faull, R. L. M., Lawlor, P. A., Beilharz, E. J., Singleton, K., Walker, E. B., & Mee, E. T. (1995) · Neuroreport · doi:10.1097/00001756-199505090-00026 · Cited by 342 · see citing works

Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors

Crotti, A., Benner, C., Kerman, B. E., Gosselin, D., Lagier-Tourenne, C., Zuccato, C., Cattaneo, E., Gage, F. H., Cleveland, D. W., & Glass, C. K. (2014) · Nature Neuroscience · doi:10.1038/nn.3668 · Cited by 333 · see citing works

The ATM protein kinase and cellular redox signaling: beyond the DNA damage response

Ditch, S., & Paull, T. T. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.10.002 · Cited by 325 · see citing works

Cell signalling by reactive lipid species: new concepts and molecular mechanisms

Higdon, A. N., Diers, A. R., Oh, J. Y., Landar, A. L., & Darley-Usmar, V. M. (2012) · Biochemical Journal · doi:10.1042/bj20111752 · Cited by 320 · see citing works

Tryptophan metabolism and oxidative stress in patients with Huntington's disease

Stoy, N., Mackay, G. M., Forrest, C., Christofides, J., Egerton, M., Stone, T., & Darlington, L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03070.x · Cited by 315 · see citing works

Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′dG

Hersch, S. M., Gevorkian, S., Marder, K., Moskowitz, C., Feigin, A., Cox, M., Como, P., Zimmerman, C., Lin, M., Zhang, L., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000194318.74946.b6 · Cited by 313 · see citing works

A randomized, placebo-controlled trial of coenzyme Q ₁₀ and remacemide in Huntington’s disease

The Huntington Study Group (2001) · Neurology · doi:10.1212/wnl.57.3.397 · Cited by 312 · see citing works

Oxidative Damage in Huntington's Disease Pathogenesis

Browne, S. E., & Beal, M. F. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.2061 · Cited by 309 · see citing works

Potential function for the Huntingtin protein as a scaffold for selective autophagy

Ochaba, J., Lukacsovich, T., Csikos, G., Zheng, S., Margulis, J., Salazar, L., Mao, K., Lau, A. L., Yeung, S. Y., Humbert, S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420103111 · Cited by 308 · see citing works

Proteomic and oxidative stress analysis in human brain samples of Huntington disease

Sorolla, M. A., Reverter‐Branchat, G., Tamarit, J., Ferrer, I., Ros, J., & Cabiscol, E. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.05.014 · Cited by 300 · see citing works

Oxidative stress and lipotoxicity

Hauck, A. K., & Bernlohr, D. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r066597 · Cited by 299 · see citing works

Age‐Dependent Striatal Excitotoxic Lesions Produced by the Endogenous Mitochondrial Inhibitor Malonate

Beal, M. F., Brouillet, E., Jenkins, B. G., Henshaw, R., Rosen, B. R., & Hyman, B. T. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03633.x · Cited by 297 · see citing works

Hypoxia-inducible Factor Prolyl 4-Hydroxylase Inhibition

Siddiq, A., Ayoub, I. A., Chavez, J. C., Aminova, L. R., Shah, S., LaManna, J. C., Patton, S. M., Connor, J. R., Cherny, R. A., Volitakis, I., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504963200 · Cited by 280 · see citing works

Delivery of GABAARs to Synapses Is Mediated by HAP1-KIF5 and Disrupted by Mutant Huntingtin

Twelvetrees, A. E., Yuen, E. Y., Arancibia‐Cárcamo, I. L., MacAskill, A. F., Rostaing, P., Lumb, M. J., Humbert, S., Triller, A., Saudou, F., Yan, Z., et al. (2010) · Neuron · doi:10.1016/j.neuron.2009.12.007 · Cited by 276 · see citing works

Induction of the Nrf2-driven Antioxidant Response Confers Neuroprotection during Mitochondrial Stress in Vivo

Shih, A. Y., Imbeault, S., Barakauskas, V., Erb, H., Jiang, L., Li, P., & Murphy, T. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414635200 · Cited by 273 · see citing works

Regional Mitochondrial Respiratory Activity in Huntington's Disease Brain

Brennan, W. A., Bird, E. D., & Aprille, J. R. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb07192.x · Cited by 265 · see citing works

Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway

Ryu, H., Lee, J.-H., Olofsson, B. A., Mwidau, A., Deodoglu, A., Escudero, M., Flemington, E. K., Azizkhan‐Clifford, J., Ferrante, R. J., & Ratan, R. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737363100 · Cited by 261 · see citing works

Sp1 and Sp3 Are Oxidative Stress-Inducible, Antideath Transcription Factors in Cortical Neurons

Ryu, H., Lee, J.-H., Zaman, K., Kubilis, J., Ferrante, R. J., Ross, B. D., Neve, R. L., & Ratan, R. R. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-09-03597.2003 · Cited by 251 · see citing works

Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease

Bogdanov, M., Andreassen, O. A., Dedeoglu, A., Ferrante, R. J., & Beal, M. F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00689.x · Cited by 248 · see citing works

Protection from mitochondrial complex II inhibition <i>in vitro</i> and <i>in vivo</i> by Nrf2-mediated transcription

Calkins, M. J., Jakel, R. J., Johnson, D. A., Chan, K., Kan, Y. W., & Johnson, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408487101 · Cited by 247 · see citing works

Evidence for a defect in NADH

Parker, W. D., Boyson, S. J., LUDER, A. S., & Parks, J. K. (1990) · Neurology · doi:10.1212/wnl.40.8.1231 · Cited by 230 · see citing works

Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington’s disease patients

Chen, C., Wu, Y., Cheng, M., Liu, J., Lee, Y., Lee, P.-W., Soong, B., & Chiu, D. T.-Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.05.093 · Cited by 226 · see citing works

Inhibition of mitochondrial protein import by mutant huntingtin

Yano, H., Baranov, S. V., Baranova, O. V., Kim, J., Pan, Y., Yablonska, S., Carlisle, D. L., Ferrante, R. J., Kim, A. H., & Friedlander, R. M. (2014) · Nature Neuroscience · doi:10.1038/nn.3721 · Cited by 226 · see citing works

Energy deficit in Huntington disease: why it matters

Mochel, F., & Haller, R. G. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45691 · Cited by 220 · see citing works

Mechanisms of Copper Ion Mediated Huntington's Disease Progression

Fox, J. H., Kama, J. A., Lieberman, G., Chopra, R., Dorsey, K., Chopra, V., Volitakis, I., Cherny, R. A., Bush, A. I., & Hersch, S. M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000334 · Cited by 216 · see citing works

Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex

Polidori, M. C., Mecocci, P., Browne, S. E., Senin, U., & Beal, M. F. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00578-9 · Cited by 211 · see citing works

Partial Inhibition of Brain Succinate Dehydrogenase by 3‐Nitropropionic Acid Is Sufficient to Initiate Striatal Degeneration in Rat

Brouillet, E., Guyot, M., Mittoux, V., Altairac, S., Condé, F., Palfi, S., & Hantraye, P. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70020794.x · Cited by 210 · see citing works

Clioquinol down-regulates mutant huntingtin expression <i>in vitro</i> and mitigates pathology in a Huntington's disease mouse model

Nguyen, T., Hamby, A., & Massa, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502177102 · Cited by 194 · see citing works

Biochemical abnormalities in Huntington's chorea brains

Stahl, W. L., & Swanson, P. D. (1974) · Neurology · doi:10.1212/wnl.24.9.813 · Cited by 185 · see citing works

Proteomic Analysis of Protein Expression and Oxidative Modification in R6/2 Transgenic Mice

Marzia Perluigi, A., Poon, H. F., Maragos, W. F., Pierce, W. M. J., Klein, J. B., Calabrese, V., Cini, C., Marco, C. M. D., & Butterfield, D. A. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500090-mcp200 · Cited by 184 · see citing works

Increased Oxidative Stress in the Nucleus Caused by Nox4 Mediates Oxidation of HDAC4 and Cardiac Hypertrophy

Matsushima, S., Kuroda, J., Ago, T., Zhai, P., Park, J. Y., Xie, L.-H., Tian, B., & Sadoshima, J. (2013) · Circulation Research · doi:10.1161/circresaha.112.279760 · Cited by 183 · see citing works

Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington’s disease gene carriers and healthy subjects

Klepac, N., Relja, M., Klepac, R., Hecimovic, S. K., Babić, T., & Trkulja, V. (2007) · Journal of Neurology · doi:10.1007/s00415-007-0611-y · Cited by 181 · see citing works

Extensive changes in DNA methylation are associated with expression of mutant huntingtin

Ng, C., Yildirim, F., Yap, Y. S., Dalin, S., Matthews, B. J., Vélez, P., Labadorf, A. T., Housman, D. E., & Fraenkel, E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221292110 · Cited by 178 · see citing works

Iron Accumulates in Huntington’s Disease Neurons: Protection by Deferoxamine

Chen, J., Marks, E. S., Lai, B. C. H., Zhang, Z., Duce, J. A., Lam, L. Q., Volitakis, I., Bush, A. I., Hersch, S. M., & Fox, J. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077023 · Cited by 176 · see citing works

Complex I Defect in muscle from patients with Huntington's disease

Arenas, J., Campos, Y., Ribacoba, R., Martín, M. A., Rubio‐Terres, C., Ablanedo, P., & Cabello, A. (1998) · Annals of Neurology · doi:10.1002/ana.410430321 · Cited by 174 · see citing works

Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease

Stack, C., Ho, D. J., Wille, E. J., Calingasan, N. Y., Williams, C. R., Liby, K. T., Sporn, M. B., Dumont, M., & Beal, M. F. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.03.017 · Cited by 171 · see citing works

Prolonged Production of Reactive Oxygen Species in Response to B Cell Receptor Stimulation Promotes B Cell Activation and Proliferation

Wheeler, M. L., & DeFranco, A. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201433 · Cited by 171 · see citing works

Evidence of Oxidant Damage in Huntington's Disease: Translational Strategies Using Antioxidants

Stack, E. C., Matson, W. R., & Ferrante, R. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.008 · Cited by 167 · see citing works

From Sulfenylation to Sulfhydration: What a Thiolate Needs to Tolerate

Finkel, T. (2012) · Science Signaling · doi:10.1126/scisignal.2002943 · Cited by 161 · see citing works

Alterations in Brain Transition Metals in Huntington Disease

Rosas, H. D., Chen, Y. I., Doros, G. D., Salat, D. H., Chen, N., Kwong, K. K., Bush, A. I., Fox, J. H., & Hersch, S. M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2945 · Cited by 160 · see citing works

Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding

Xiao, G., Fan, Q., Wang, X., & Zhou, B. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1308535110 · Cited by 158 · see citing works

Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid

Guyot, M., Hantraye, P., Dolan, R., Palfi, S., Mazière, M., & Brouillet, E. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00602-1 · Cited by 158 · see citing works

Efficacy of Fumaric Acid Esters in the R6/2 and YAC128 Models of Huntington's Disease

Ellrichmann, G., Petrasch‐Parwez, E., Lee, D.-H., Reick, C., Arning, L., Carsten Saft, C., Gold, R., & Linker, R. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016172 · Cited by 155 · see citing works

Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons from oxidative stress via an Nrf2-independent pathway

Haskew-Layton, R. E., Payappilly, J. B., Smirnova, N. A., Ma, T. C., Chan, K. K., Murphy, T. H., Guo, H., Langley, B. C., Rukhsana Sultana, A., Butterfield, D. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003996107 · Cited by 151 · see citing works

Mitochondrial DNA damage Is associated with reduced mitochondrial bioenergetics in Huntington's disease

Siddiqui, A., Rivera, S., Castro, M. D. R., Acevedo‐Torres, K., Rane, A., Torres‐Ramos, C. A., Nicholls, D. G., Andersen, J. K., & Ayala‐Torres, S. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.06.008 · Cited by 150 · see citing works

Stoichiometry of Base Excision Repair Proteins Correlates with Increased Somatic CAG Instability in Striatum over Cerebellum in Huntington's Disease Transgenic Mice

Goula, A.-V., Berquist, B. R., Wilson, D. M., Wheeler, V. C., Trottier, Y., & Mérienne, K. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000749 · Cited by 145 · see citing works

Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial

† (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70262-5 · Cited by 144 · see citing works

Role of oxidative DNA damage in mitochondrial dysfunction and Huntington’s disease pathogenesis

Ayala‐Peña, S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.017 · Cited by 142 · see citing works

Mutant huntingtin impairs Ku70-mediated DNA repair

Enokido, Y., Tamura, T., Ito, H., Arumughan, A., Komuro, A., Shiwaku, H., Sone, M., Foulle, R., Sawada, H., Ishiguro, H., et al. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.200905138 · Cited by 141 · see citing works

Therapeutic targeting of oxygen-sensing prolyl hydroxylases abrogates ATF4-dependent neuronal death and improves outcomes after brain hemorrhage in several rodent models

Karuppagounder, S. S., Alim, I., Khim, S. J., Bourassa, M. W., Sleiman, S. F., John, R., Thinnes, C. C., Yeh, T.-L., Demetriades, M., Neitemeier, S., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aac6008 · Cited by 141 · see citing works

Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington’s disease

Lu, X., Mattis, V. B., Wang, N., Al‐Ramahi, I., van den Berg, N., Fratantoni, S. A., Waldvogel, H. J., Greiner, E. R., Osmand, A., Merz, K. E., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3010523 · Cited by 138 · see citing works

Redox Regulation of DNA Repair: Implications for Human Health and Cancer Therapeutic Development

Luo, M., He, H., Kelley, M. R., & Georgiadis, M. M. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2698 · Cited by 136 · see citing works

Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington’s disease

Pérez‐Severiano, F., Rı́os, C., & Segovia, J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02082-5 · Cited by 135 · see citing works

Selective expression of mutant huntingtin during development recapitulates characteristic features of Huntington’s disease

Molero, A. E., Arteaga-Bracho, E. E., Chen, C. H., Gulinello, M. E., Winchester, M. L., Pichamoorthy, N., Gökhan, Ş., Khodakhah, K., & Mehler, M. F. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603871113 · Cited by 132 · see citing works

Mechanisms of synaptic dysfunction and excitotoxicity in Huntington's disease

Sepers, M. D., & Raymond, L. A. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.02.006 · Cited by 127 · see citing works

Mitochondrial DNA damage is a hallmark of chemically induced and the R6/2 transgenic model of Huntington's disease

Acevedo‐Torres, K., Berríos, L., Rosario, N., Dufault, V. M., Skatchkov, S. N., Eaton, M. J., Torres‐Ramos, C. A., & Ayala‐Torres, S. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.09.004 · Cited by 126 · see citing works

Reversible oxidation of ERK-directed protein phosphatases drives oxidative toxicity in neurons

Levinthal, D. J., & DeFranco, D. B. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410771200 · Cited by 126 · see citing works

Systemic 3-nitropropionic acid: Behavioral deficits and striatal damage in adult rats

Borlongan, C. V., Koutouzis, T. K., Randall, T. S., Freeman, T. B., Cahill, D. W., & Sanberg, P. R. (1995) · Brain Research Bulletin · doi:10.1016/0361-9230(94)00242-s · Cited by 122 · see citing works

Iron dysregulation in Huntington's disease

Müller, M., & Leavitt, B. R. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12739 · Cited by 122 · see citing works

HACE1 reduces oxidative stress and mutant Huntingtin toxicity by promoting the NRF2 response

Rotblat, B., Southwell, A. L., Ehrnhoefer, D. E., Skotte, N. H., Metzler, M., Franciosi, S., Leprivier, G., Somasekharan, S. P., Barokas, A., Deng, Y., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314421111 · Cited by 111 · see citing works

The emerging role of ROS-generating NADPH oxidase NOX4 in DNA-damage responses

Weyemi, U., & Dupuy, C. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.04.002 · Cited by 111 · see citing works

Apolipoprotein E Affects Both Myelin Breakdown and Cognition: Implications for Age-Related Trajectories of Decline Into Dementia

Bartzokis, G., Lu, P. H., Geschwind, D. H., Tingus, K., Huang, D., Mendez, M. F., Edwards, N., & Mintz, J. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.024 · Cited by 109 · see citing works

An environment to nucleus' signaling system operates in B lymphocytes: redox status modulates BSAP/Pax-5 activation through Ref-1 nuclear translocation

Tell, G. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.5.1099 · Cited by 109 · see citing works

Assessment of coenzyme q10 tolerability in huntington's disease

Feigin, A., Kieburtz, K. D., Como, P. G., Hickey, C., Abwender, D. A., Zimmerman, C., Steinberg, K., & Shoulson, I. (1996) · Movement Disorders · doi:10.1002/mds.870110317 · Cited by 108 · see citing works

Redox Regulation of MAP Kinase Phosphatase 3

Seth, D., & Rudolph, J. (2006) · Biochemistry · doi:10.1021/bi060157p · Cited by 105 · see citing works

In Vitro and in Vivo Aggregation of a Fragment of Huntingtin Protein Directly Causes Free Radical Production

Hands, S. L., Sajjad, M. U., Newton, M. J., & Wyttenbach, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.307587 · Cited by 103 · see citing works

Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington’s disease

Hong, C., Seo, H., Kwak, M., Jeon, J., Jang, J., Jeong, E. M., Myeong, J., Hwang, Y. J., Ha, K., Kang, M. J., et al. (2015) · Brain · doi:10.1093/brain/awv188 · Cited by 101 · see citing works

Neuronal identity genes regulated by super-enhancers are preferentially down-regulated in the striatum of Huntington's disease mice

Achour, M., Gras, S. L., Keime, C., Parmentier, F., Lejeune, F., Boutillier, A., Néri, C., Davidson, I., & Mérienne, K. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv099 · Cited by 99 · see citing works

A controlled trial of idebenone in Huntington's disease

Ranen, N. G., Peyser, C. E., Coyle, J. T., Bylsma, F. W., Sherr, M., Day, L., Folstein, M. F., Brandt, J., Ross, C. A., & Folstein, S. E. (1996) · Movement Disorders · doi:10.1002/mds.870110510 · Cited by 97 · see citing works

Clinical correlates of mitochondrial function in Huntington's disease muscle

Turner, C., Cooper, J. M., & Schapira, A. H. V. (2007) · Movement Disorders · doi:10.1002/mds.21540 · Cited by 97 · see citing works

Development of Neh2-Luciferase Reporter and Its Application for High Throughput Screening and Real-Time Monitoring of Nrf2 Activators

Smirnova, N. A., Haskew-Layton, R. E., Basso, M., Hushpulian, D. M., Payappilly, J. B., Speer, R. E., Ahn, Y., Rakhman, I., Cole, P. A., Pinto, J. T., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.03.013 · Cited by 96 · see citing works

Allocortical involvement in Huntington's disease

Braak, H., & Braak, E. (1992) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1992.tb00824.x · Cited by 96 · see citing works

Age-dependent changes in nitric oxide synthase activity and protein expression in striata of mice transgenic for the Huntington's disease mutation.

Pérez-Severiano, F., Escalante, B., Vergara, P., Ríos, C., & Segovia, J. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03102-5 · Cited by 95 · see citing works

DNA breakage and induction of DNA damage response proteins precede the appearance of visible mutant huntingtin aggregates

Illuzzi, J. L., Yerkes, S., Parekh‐Olmedo, H., & Kmiec, E. B. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21881 · Cited by 94 · see citing works

Important Role of Oxidative Stress Biomarkers in Huntington’s Disease

Túnez, I., Sánchez‐López, F., Agüera, E., Fernández‐Bolaños, R., Sánchez, F. M., & Tasset-Cuevas, I. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200605a · Cited by 93 · see citing works

Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism

Sorolla, M. A., Colman, M. J. R., Tamarit, J., Ortega, Z., Lucas, J. J., Ferrer, I., Ros, J., & Cabiscol, E. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.05.016 · Cited by 91 · see citing works

Chasing Cysteine Oxidative Modifications

Murray, C. I., & Eyk, J. E. V. (2012) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.111.961425 · Cited by 88 · see citing works

Reactive Cysteines of the 90-kDa Heat Shock Protein, Hsp90

Nardai, G., Sass, B., Eber, J., Orosz, G., & Csermely, P. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.2075 · Cited by 84 · see citing works

Suppression of Somatic Expansion Delays the Onset of Pathophysiology in a Mouse Model of Huntington’s Disease

Budworth, H., Harris, F. R., Williams, P. T., Lee, D. Y., Holt, A., Pahnke, J., Szczęsny, B., Acevedo‐Torres, K., Ayala‐Peña, S., & McMurray, C. T. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005267 · Cited by 82 · see citing works

Astrocyte-Specific Overexpression of Nrf2 Protects Striatal Neurons from Mitochondrial Complex II Inhibition

Calkins, M. J., Vargas, M. R., Johnson, D. A., & Johnson, J. A. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq072 · Cited by 82 · see citing works

Transcriptional dysregulation in Huntington's disease: a failure of adaptive transcriptional homeostasis

Kumar, A., Vaish, M., & Ratan, R. R. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.03.016 · Cited by 82 · see citing works

PBT2 Reduces Toxicity in a C. elegans Model of polyQ Aggregation and Extends Lifespan, Reduces Striatal Atrophy and Improves Motor Performance in the R6/2 Mouse Model of Huntington's Disease

Cherny, R. A., Ayton, S., Finkelstein, D. I., Bush, A. I., McColl, G., & Massa, S. M. (2012) · Journal of Huntington s Disease · doi:10.3233/jhd-120029 · Cited by 78 · see citing works

Scavenging of H2O2 by mouse brain mitochondria

Starkov, A. A., Andreyev, A. Y., Zhang, S. F., Starkova, N. N., Korneeva, M., Syromyatnikov, M., & Popov, V. N. (2014) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-014-9581-9 · Cited by 78 · see citing works

Early Alterations in Gene Expression and Cell Morphology in a Mouse Model of Huntington's Disease

Iannicola, C., Moreno, S., Oliverio, S., Nardacci, R., Ciofi-Luzzatto, A., & Piacentini, M. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750830.x · Cited by 74 · see citing works

Neil1 is a genetic modifier of somatic and germline CAG trinucleotide repeat instability in R6/1 mice

Møllersen, L., Rowe, A. D., Illuzzi, J. L., Hildrestrand, G. A., Gerhold, K. J., Tveterås, L., Bjølgerud, A., Wilson, D. M., Bjørås, M., & Klungland, A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds337 · Cited by 74 · see citing works

8OHdG as a marker for Huntington disease progression

Long, J. D., Matson, W. R., Juhl, A. R., Leavitt, B. R., & Paulsen, J. S. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.02.012 · Cited by 71 · see citing works

Structure-Dependent DNA Damage and Repair in a Trinucleotide Repeat Sequence

Jarem, D. A., Wilson, N. R., & Delaney, S. (2009) · Biochemistry · doi:10.1021/bi9007403 · Cited by 71 · see citing works

Cysteine Oxidation within N-terminal Mutant Huntingtin Promotes Oligomerization and Delays Clearance of Soluble Protein

Fox, J. H., Connor, T., Stiles, M. A., Kama, J. A., Lü, Z., Dorsey, K., Liebermann, G., Sapp, E., Cherny, R. A., Banks, M., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.199448 · Cited by 68 · see citing works

Aberrantly splicedHTT,a new player in Huntington’s disease pathogenesis

Gipson, T. A., Neueder, A., Wexler, N. S., Bates, G. P., & Housman, D. E. (2013) · RNA Biology · doi:10.4161/rna.26706 · Cited by 65 · see citing works

Potassium bromate, a potent DNA oxidizing agent, exacerbates germline repeat expansion in a fragile X premutation mouse model

Entezam, A., Lokanga, R. A., Le, W. W., Hoffman, G. E., & Usdin, K. (2010) · Human Mutation · doi:10.1002/humu.21237 · Cited by 64 · see citing works

Mitochondrial targeting of XJB-5-131 attenuates or improves pathophysiology in HdhQ150 animals with well-developed disease phenotypes

Polyzos, A. A., Holt, A., Brown, C., Cosme, C. G., Wipf, P., Gómez-Marín, À., Castro, M. D. R., Ayala‐Peña, S., & McMurray, C. T. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw051 · Cited by 62 · see citing works

Protein s-glutathionylation in retinal pigment epithelium converts heat shock protein 70 to an active chaperone

Hoppe, G., Chai, Y.-C., Crabb, J. W., & Sears, J. E. (2004) · Experimental Eye Research · doi:10.1016/j.exer.2004.02.001 · Cited by 61 · see citing works

Pharmacodynamics of Dimethyl Fumarate Are Tissue Specific and Involve NRF2-Dependent and -Independent Mechanisms

Brennan, M. S., Patel, H., Allaire, N., Thai, A., Cullen, P. F., Ryan, S. T., Lukashev, M., Bista, P., Huang, R., Rhodes, K. J., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6622 · Cited by 57 · see citing works

Metallothioneins and copper metabolism are candidate therapeutic targets in Huntington's disease

Hands, S. L., Mason, R. P., Sajjad, M. U., Giorgini, F., & Wyttenbach, A. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380552 · Cited by 55 · see citing works

Downregulation of NF-κB signaling by mutant huntingtin proteins induces oxidative stress and cell death

Reijonen, S., Kukkonen, J. P., Hyrskyluoto, A., Kivinen, J., Kairisalo, M., Takei, N., Lindholm, D., & Korhonen, L. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0305-y · Cited by 55 · see citing works

The expression of the Na+/glucose cotransporter (SGLT1) gene in lamb small intestine during postnatal development

Freeman, T. C., Wood, I. S., SIRINATHSINGHJI, D. J. S., BEECHEY, R. B., Dyer, J., & Shirazi‐Beechey, S. P. (1993) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(93)90357-6 · Cited by 53 · see citing works

Randomized Controlled Trial of Ethyl-Eicosapentaenoic Acid in Huntington Disease

Huntington Study Group TREND-HD Investigators (2008) · Archives of Neurology · doi:10.1001/archneur.65.12.1582 · Cited by 49 · see citing works

Disruption of immune cell function by mutant huntingtin in Huntington's disease pathogenesis

André, R., Carty, L., & Tabrizi, S. J. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.09.008 · Cited by 48 · see citing works

The role of IκB kinase complex in the neurobiology of Huntington's disease

Khoshnan, A., & Patterson, P. H. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.04.015 · Cited by 47 · see citing works

Protein oxidation in Huntington disease

Sorolla, M. A., Colman, M. J. R., Vall‐llaura, N., Tamarit, J., Ros, J., & Cabiscol, E. (2012) · BioFactors · doi:10.1002/biof.1013 · Cited by 47 · see citing works

Blood 5‐hydroxytryptamine, 5‐hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury

Christofides, J. A., Bridel, M. A., Egerton, M., Mackay, G., Forrest, C. M., Stoy, N. S., Darlington, L. G., & Stone, T. W. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03807.x · Cited by 44 · see citing works

Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription

Calkins, M. J., Townsend, J. A., Johnson, D. A., & Johnson, J. A. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.04.008 · Cited by 40 · see citing works

Safety and tolerability of the free-radical scavenger OPC-14117 in Huntington's disease

The Huntington Study Group* (1998) · Neurology · doi:10.1212/wnl.50.5.1366 · Cited by 38 · see citing works

Dithiol-based Compounds Maintain Expression of Antioxidant Protein Peroxiredoxin 1 That Counteracts Toxicity of Mutant Huntingtin

Pitts, A., Dailey, K. M., Newington, J. T., Chien, A., Arseneault, R., Cann, T., Thompson, L. M., & Cumming, R. C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.334565 · Cited by 35 · see citing works

Downregulation of Genes Involved in Metabolism and Oxidative Stress in the Peripheral Leukocytes of Huntington's Disease Patients

Chang, K., Chen, Y., Wu, Y., Lee, W.-F., & Chen, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046492 · Cited by 31 · see citing works

Post-aggregation Oxidation of Mutant Huntingtin Controls the Interactions between Aggregates

Mitomi, Y., Nomura, T., Kurosawa, M., Nukina, N., & Furukawa, Y. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.387035 · Cited by 31 · see citing works

Normal platelet mitochondrial complex I activity in Huntington’s Disease

Powers, W. J., Haas, R., Le, T. P., Videen, T. O., Hershey, T. G., McGee‐Minnich, L., & Perlmutter, J. S. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.04.008 · Cited by 30 · see citing works

Association of status redox with demographic, clinical and imaging parameters in patients with Huntington's disease

Peña-Sánchez, M., Forment, G. R., Zaldívar-Vaillant, T., Lavastida, A. S., Borrero-Sánchez, J., Fernández, G. L., Esteban, E. M., Hernández-Díaz, Z. M., González‐Quevedo, A., Fernández-Almirall, I., et al. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.06.014 · Cited by 26 · see citing works

Oxidized dNTPs and the OGG1 and MUTYH DNA glycosylases combine to induce CAG/CTG repeat instability

Cilli, P., Ventura, I., Minoprio, A., Meccia, E., Martire, A., Wilson, S. H., Bignami, M., & Mazzei, F. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw170 · Cited by 24 · see citing works

Peripheral biomarkers of oxidative stress and their limited potential in evaluation of clinical features of Huntington's patients

Ciancarelli, I., Amicis, D. D., Massimo, C. D., Scanno, C. D., Pistarini, C., D’Orazio, N., & Ciancarelli, M. G. T. (2014) · Biomarkers · doi:10.3109/1354750x.2014.935955 · Cited by 23 · see citing works

Putting Huntingtin “Aggregation” in View with Windows into the Cellular Milieu

Hatters, D. M. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611212220013 · Cited by 18 · see citing works

Time-Course Analysis of Protein and Lipid Oxidation in the Brains of Yac128 Huntington's Disease Transgenic Mice

Brocardo, P. S., McGinnis, E., Christie, B. R., & Gil‐Mohapel, J. (2015) · Rejuvenation Research · doi:10.1089/rej.2015.1736 · Cited by 15 · see citing works

Reagents that block neuronal death from Huntington’s disease also curb oxidative stress

Valencia, A., Sapp, E., Reeves, P., Alexander, J. S., Masso, N., Li, X., Kegel, K. B., & DiFiglia, M. (2011) · Neuroreport · doi:10.1097/wnr.0b013e32834d92e6 · Cited by 15 · see citing works

Transcription Blockage Leads to New Beginnings

de Andrade-Lima, L. C., Veloso, A., & Ljungman, M. E. (2015) · Biomolecules · doi:10.3390/biom5031600 · Cited by 14 · see citing works

Antioxidant and Metal Chelation-Based Therapies in the Treatment of Prion Disease

Brazier, M. W., Wedd, A. G., & Collins, S. J. (2014) · Antioxidants · doi:10.3390/antiox3020288 · Cited by 14 · see citing works

Problems and solutions for the analysis of somatic CAG repeat expansion and their relationship to Huntington's disease toxicity

Budworth, H., & McMurray, C. T. (2016) · Rare Diseases · doi:10.1080/21675511.2015.1131885 · Cited by 6 · see citing works

Oxidative Stress: A Key Modulator in Neurodegenerative Diseases

Singh, A., Kukreti, R., Saso, L., & Kukreti, S. (2019) · Molecules · doi:10.3390/molecules24081583 · Cited by 2,305 · see citing works

Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease

Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130 · see citing works

Essential metals in health and disease

Jomova, K., Makova, M., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., Rhodes, C. J., & Valko, M. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110173 · Cited by 1,121 · see citing works

An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases

Teleanu, D. M., Niculescu, A.-G., Lungu, I. I., Radu, C. I., Vladâcenco, O., Roza, E., Costăchescu, B., Grumezescu, A. M., & Teleanu, R. I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115938 · Cited by 1,085 · see citing works

Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications

Liu, Z., Zhou, T., Ziegler, A. C., Dimitrion, P., & Zuo, L. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2525967 · Cited by 810 · see citing works

Function and therapeutic value of astrocytes in neurological diseases

Lee, H.-G., Wheeler, M. A., & Quintana, F. J. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00390-x · Cited by 662 · see citing works

Functions and dysfunctions of nitric oxide in brain

Picón-Pagès, P., Garcia-Buendia, J., & Muñoz, F. J. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.11.007 · Cited by 357 · see citing works

Scavenging of reactive oxygen and nitrogen species with nanomaterials

Ferreira, C. A., Ni, D., Rosenkrans, Z. T., & Cai, W. (2018) · Nano Research · doi:10.1007/s12274-018-2092-y · Cited by 302 · see citing works

Cellular functions of the protein kinase ATM and their relevance to human disease

Lee, J., & Paull, T. T. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00394-2 · Cited by 290 · see citing works

Neuroprotective Strategies for Neurological Disorders by Natural 
Products: An update

Rehman, M., Wali, A., Ahmad, A., Shakeel, S., Rasool, S., Ali, R., Rashid, S. M., Madkhali, H. A., Ganaie, M., & Khan, R. (2019) · Current Neuropharmacology · doi:10.2174/1570159x16666180911124605 · Cited by 202 · see citing works

Striatal neurons directly converted from Huntington’s disease patient fibroblasts recapitulate age-associated disease phenotypes

Victor, M. B., Richner, M., Olsen, H. E., Lee, S. W., Monteys, A. M., Ma, C., Huh, C. J., Zhang, B., Davidson, B. L., Yang, X. W., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0075-7 · Cited by 246 · see citing works

Oxidative Stress and Immune System Dysfunction in Autism Spectrum Disorders

Pangrazzi, L., Balasco, L., & Bozzi, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093293 · Cited by 219 · see citing works

Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases

Konovalova, J., Gerasymchuk, D., Parkkinen, I., Chmielarz, P., & Domanskyi, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236055 · Cited by 199 · see citing works

3-Nitrotyrosine: a versatile oxidative stress biomarker for major neurodegenerative diseases

Bandookwala, M., & Sengupta, P. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1713776 · Cited by 187 · see citing works

Are Astrocytes the Predominant Cell Type for Activation of Nrf2 in Aging and Neurodegeneration?

Liddell, J. R. (2017) · Antioxidants · doi:10.3390/antiox6030065 · Cited by 167 · see citing works

Interaction of Mitochondrial Calcium and ROS in Neurodegeneration

Baev, A. Y., Vinokurov, A. Y., Novikova, I. N., Dremin, V. V., Potapova, E. V., & Abramov, A. Y. (2022) · Cells · doi:10.3390/cells11040706 · Cited by 162 · see citing works

Selenium Nanoparticles as an Efficient Nanomedicine for the Therapy of Huntington’s Disease

Cong, W., Bai, R., Li, Y., Wang, L., & Chen, C. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b12319 · Cited by 162 · see citing works

Redox Mechanisms in Neurodegeneration: From Disease Outcomes to Therapeutic Opportunities

Sbodio, J. I., Snyder, S. H., & Paul, B. D. (2018) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7321 · Cited by 143 · see citing works

Oxidative Stress and Cognitive Decline: The Neuroprotective Role of Natural Antioxidants

Franzoni, F., Scarfò, G., Guidotti, S., Fusi, J., Асомов, М. И., & Pruneti, C. A. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.729757 · Cited by 136 · see citing works

Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments

Rehman, M. U., Sehar, N., Dar, N. J., Khan, A., Arafah, A., Rashid, S., Rashid, S. M., & Ganaie, M. A. (2023) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104961 · Cited by 130 · see citing works

Current and Possible Future Therapeutic Options for Huntington’s Disease

Ferguson, M. W., Kennedy, C. J., Palpagama, T. H., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2022) · Journal of Central Nervous System Disease · doi:10.1177/11795735221092517 · Cited by 126 · see citing works

Interaction of Oxidative Stress and Misfolded Proteins in the Mechanism of Neurodegeneration

Abramov, A. Y., Potapova, E., Владимирович, Д. В., & Dunaev, A. (2020) · Life · doi:10.3390/life10070101 · Cited by 125 · see citing works

Cysteine Depletion, a Key Action to Challenge Cancer Cells to Ferroptotic Cell Death

Daher, B., Vučetić, M., & Pouysségur, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00723 · Cited by 117 · see citing works

The neuroprotective potential of carotenoids in vitro and in vivo

Manochkumar, J., Doss, C. G. P., El-Seedi, H. R., Efferth, T., & Ramamoorthy, S. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153676 · Cited by 115 · see citing works

Antioxidants and Nanotechnology: Promises and Limits of Potentially Disruptive Approaches in the Treatment of Central Nervous System Diseases

Martinelli, C., Pucci, C., Battaglini, M., Marino, A., & Ciofani, G. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201901589 · Cited by 111 · see citing works

New Insights into Oxidative Stress and Inflammatory Response in Neurodegenerative Diseases

Scarian, E., Viola, C., Dragoni, F., Gerlando, R. D., Rizzo, B., Diamanti, L., Gagliardi, S., Bordoni, M., & Pansarasa, O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052698 · Cited by 115 · see citing works

An attempt to elucidate the role of iron and zinc ions in development of Alzheimer’s and Parkinson’s diseases

Wojtunik‐Kulesza, K. A., Oniszczuk, A., & Waksmundzka‐Hajnos, M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.140 · Cited by 102 · see citing works

Polyunsaturated Fatty Acid Deuteration against Neurodegeneration

Shchepinov, M. S. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.01.010 · Cited by 86 · see citing works

DJ-1 in neurodegenerative diseases: Pathogenesis and clinical application

Huang, M., & Chen, S. (2021) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2021.102114 · Cited by 87 · see citing works

The role of oxidative stress in neurodegenerative diseases and potential antioxidant therapies

Bailo, P. S., Martín, E. L., Calmarza, P., Breva, S. M., Gómez, A. B., Giráldez, A. P., Callau, J. J. S.-P., Santamaría, J. M. V., Dayaldasani, A., Micó, C. C., et al. (2022) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2022-0111 · Cited by 84 · see citing works

Impaired antioxidant KEAP1-NRF2 system in amyotrophic lateral sclerosis: NRF2 activation as a potential therapeutic strategy

Bono, S., Feligioni, M., & Corbo, M. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00479-8 · Cited by 83 · see citing works

Unraveling the complexity of human brain: Structure, function in healthy and disease states

Sultana, O. F., Bandaru, M., Islam, M. A., & Reddy, P. H. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102414 · Cited by 88 · see citing works

Ferroptosis and Iron Homeostasis: Molecular Mechanisms and Neurodegenerative Disease Implications

Abdukarimov, N., Kokabi, K., & Kunz, J. (2025) · Antioxidants · doi:10.3390/antiox14050527 · Cited by 83 · see citing works

Huntington Disease as a Neurodevelopmental Disorder and Early Signs of the Disease in Stem Cells

Wiatr, K., Szlachcic, W. J., Trzeciak, M., Figlerowicz, M., & Figiel, M. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0477-7 · Cited by 81 · see citing works

Amyloid cross-seeding raises new dimensions to understanding of amyloidogenesis mechanism

Chaudhuri, P., Prajapati, K. P., Anand, B. G., Dubey, K., & Kar, K. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100937 · Cited by 78 · see citing works

Nanozyme-based strategies for efficient theranostics of brain diseases

Xu, R., Zhang, S., Wang, P., Zhang, R., Lin, P., Wang, Y., Gao, L., Wei, H., Zhang, X., Ling, D., et al. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215519 · Cited by 77 · see citing works

Molecular Pathogenesis in Huntington’s Disease

Illarioshkin, S. N., Klyushnikov, S. A., Vigont, V. A., Seliverstov, Y. A., & Kaznacheyeva, E. V. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918090043 · Cited by 74 · see citing works

FMN reduces Amyloid-β toxicity in yeast by regulating redox status and cellular metabolism

Chen, X., Ji, B., Hao, X., Li, X., Eisele, F., Nyström, T., & Petranović, D. (2020) · Nature Communications · doi:10.1038/s41467-020-14525-4 · Cited by 73 · see citing works

Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy

André, L. M., Ausems, C. R. M., Wansink, D. G., & Wieringa, B. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00368 · Cited by 68 · see citing works

The neuroprotective activities of natural products through the Nrf2 upregulation

Tavakkoli, A., Iranshahi, M., Hasheminezhad, S. H., Hayes, A. W., & Karimi, G. (2019) · Phytotherapy Research · doi:10.1002/ptr.6427 · Cited by 68 · see citing works

Reactive Oxygen Species: Angels and Demons in the Life of a Neuron

Biswas, K., Alexander, K. D., & Francis, M. M. (2022) · NeuroSci · doi:10.3390/neurosci3010011 · Cited by 69 · see citing works

N6-Furfuryladenine is protective in Huntington’s disease models by signaling huntingtin phosphorylation

Bowie, L. E., Maiuri, T., Alpaugh, M., Gabriel, M. A., Arbez, N., Galleguillos, D., Hung, C. L.-K., Patel, S., Xia, J., Hertz, N. T., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801772115 · Cited by 66 · see citing works

Protective Effects of Antioxidants in Huntington’s Disease: an Extensive Review

Essa, M. M., Moghadas, M., Ba-Omar, T., Qoronfleh, M. W., Guillemin, G. J., Manivasagam, T., Justin‐Thenmozhi, A., Ray, B., Bhat, A., Chidambaram, S. B., et al. (2019) · Neurotoxicity Research · doi:10.1007/s12640-018-9989-9 · Cited by 68 · see citing works

Nucleo–cytoplasmic transport defects and protein aggregates in neurodegeneration

Bitetto, G., & Fonzo, A. D. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00205-2 · Cited by 66 · see citing works

Neuroprotective effects of oleuropein: Recent developments and contemporary research

Butt, M. S., Tariq, U., Ul‐Haq, I., Naz, A., & Rizwan, M. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13967 · Cited by 65 · see citing works

Mitochondrial Permeability Transition, Cell Death and Neurodegeneration

Baev, A. Y., Vinokurov, A. Y., Potapova, E., Dunaev, A., Angelova, P. R., & Abramov, A. Y. (2024) · Cells · doi:10.3390/cells13070648 · Cited by 65 · see citing works

The Role of Dietary Antioxidants in the Pathogenesis of Neurodegenerative Diseases and Their Impact on Cerebral Oxidoreductive Balance

Winiarska‐Mieczan, A., Baranowska‐Wójcik, E., Kwiecień, M., GRELA, E. R., Szwajgier, D., Kwiatkowska, K., & Kiczorowska, B. (2020) · Nutrients · doi:10.3390/nu12020435 · Cited by 61 · see citing works

Increased translation as a novel pathogenic mechanism in Huntington’s disease

Creus‐Muncunill, J., Badillos-Rodríguez, R., García-Forn, M., Masana, M., Barriga, G. G.-D., Guisado-Corcoll, A., Alberch, J., Malagelada, C., Delgado-Garcia, J. M., Gruart, A., et al. (2019) · Brain · doi:10.1093/brain/awz230 · Cited by 58 · see citing works

Targeting ferroptosis in gastric cancer: Strategies and opportunities

Le, J., Pan, G., Zhang, C., Chen, Y., Tiwari, A. K., & Qin, J. (2023) · Immunological Reviews · doi:10.1111/imr.13280 · Cited by 61 · see citing works

The Complex Mechanisms by Which Neurons Die Following DNA Damage in Neurodegenerative Diseases

Shadfar, S., Brocardo, M. G., & Atkin, J. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052484 · Cited by 54 · see citing works

AMPK and its Activator Berberine in the Treatment of Neurodegenerative Diseases

Qin, S., Tang, H., Li, W., Gong, Y., Li, S., Huang, J., Fang, Y., Yuan, W., Liu, Y., Wang, S., et al. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200523172334 · Cited by 53 · see citing works

The interplay between redox signalling and proteostasis in neurodegeneration: In vivo effects of a mitochondria-targeted antioxidant in Huntington's disease mice

Pinho, B. R., Duarte, A. I., Canas, P. M., Moreira, P. I., Murphy, M. P., & Oliveira, J. M. A. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.11.021 · Cited by 54 · see citing works

Detecting Oxidative Stress Biomarkers in Neurodegenerative Disease Models and Patients

Sidorova, Y. A., & Domanskyi, A. (2020) · Methods and Protocols · doi:10.3390/mps3040066 · Cited by 51 · see citing works

Liraglutide Improves Cognitive and Neuronal Function in 3-NP Rat Model of Huntington’s Disease

Shawki, S. M., Saad, M. A., Rahmo, R. M., Wadie, W., & El-Abhar, H. S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.731483 · Cited by 51 · see citing works

Deuterium‐reinforced linoleic acid lowers lipid peroxidation and mitigates cognitive impairment in the Q140 knock in mouse model of Huntington's disease

Hatami, A., Zhu, C., Relaño-Ginés, A., Elias, C. J., Galstyan, A., Jun, M., Milne, G. L., Cantor, C. R., Chesselet, M., & Shchepinov, M. S. (2018) · FEBS Journal · doi:10.1111/febs.14590 · Cited by 51 · see citing works

Mitochondrial superoxide generation induces a parkinsonian phenotype in zebrafish and huntingtin aggregation in human cells

Pinho, B. R., Reis, S., Hartley, R. C., Murphy, M. P., & Oliveira, J. M. A. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.446 · Cited by 50 · see citing works

Reactive Species in Huntington Disease: Are They Really the Radicals You Want to Catch?

Bono-Yagüe, J., Gómez-Escribano, A. P., Millán, J. M., & Vázquez‐Manrique, R. P. (2020) · Antioxidants · doi:10.3390/antiox9070577 · Cited by 49 · see citing works

2,4 DNP improves motor function, preserves medium spiny neuronal identity, and reduces oxidative stress in a mouse model of Huntington's disease

Wu, B., Jiang, M., Peng, Q., Li, G., Hou, Z., Milne, G. L., Mori, S., Alonso, R. J., Geisler, J. G., & Duan, W. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.03.020 · Cited by 46 · see citing works

Significance of Antioxidants in the Treatment and Prevention of Neurodegenerative Diseases

Fadaka, A. O., Ajiboye, B. O., Adewale, I., Ojo, O. A., Oyinloye, B. E., & Okesola, M. A. (2019) · The Journal of Phytopharmacology · doi:10.31254/phyto.2019.8210 · Cited by 46 · see citing works

Role of Antioxidants in Modulating the Microbiota–Gut–Brain Axis and Their Impact on Neurodegenerative Diseases

Kurhaluk, N., Kamiński, P., Bilski, R., Kołodziejska, R., Woźniak, A., & Ткаченко, Г. М. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083658 · Cited by 49 · see citing works

Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington’s disease

Sharma, P., Kumar, M., & Bansal, N. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02106-1 · Cited by 42 · see citing works

Role of plant derived alkaloids as antioxidant agents for neurodegenerative diseases

Şirin, S., Dolanbay, S. N., & Aslım, B. (2022) · Health Sciences Review · doi:10.1016/j.hsr.2022.100071 · Cited by 41 · see citing works

Signaling Pathways in Oxidative Stress-Induced Neurodegenerative Diseases: A Review of Phytochemical Therapeutic Interventions

Sebghatollahi, Z., Yogesh, R., Mahato, N., Kumar, V., Mohanta, Y. K., Baek, K.-H., & Mishra, A. K. (2025) · Antioxidants · doi:10.3390/antiox14040457 · Cited by 41 · see citing works

Mitochondrial dysfunction in cellular senescence: a bridge to neurodegenerative disease

Hruby, A. J., & Higuchi‐Sanabria, R. (2025) · npj Aging · doi:10.1038/s41514-025-00291-4 · Cited by 44 · see citing works

Glycogen synthase protects neurons from cytotoxicity of mutant huntingtin by enhancing the autophagy flux

Rai, A., Singh, P. K., Singh, V. P., Kumar, V., Mishra, R., Thakur, A. K., Mahadevan, A., Shankar, S. K., Jana, N. R., & Ganesh, S. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0190-5 · Cited by 37 · see citing works

Epigenetic Regulators of Neuronal Ferroptosis Identify Novel Therapeutics for Neurological diseases: HDACs, Transglutaminases, and HIF prolyl hydroxylases

Rroji, O., Kumar, A., Karuppagounder, S. S., & Ratan, R. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105145 · Cited by 29 · see citing works

Metabolic dysregulation in Huntington's disease: Neuronal and glial perspectives

Chang, C., Wu, C.-W., & Chern, Y. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106672 · Cited by 35 · see citing works

Therapeutic Strategies in Huntington’s Disease: From Genetic Defect to Gene Therapy

Jurcău, A., & Jurcău, M. C. (2022) · Biomedicines · doi:10.3390/biomedicines10081895 · Cited by 36 · see citing works

Nicotinamide reverses behavioral impairments and provides neuroprotection in 3˗nitropropionic acid induced animal model ofHuntington’s disease: implication of oxidative stress˗ poly(ADP˗ ribose) polymerase pathway

Sidhu, A., Diwan, V., Kaur, H., Bhateja, D., Singh, C. K., Sharma, S., & Padi, S. S. V. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0297-0 · Cited by 32 · see citing works

A transition to degeneration triggered by oxidative stress in degenerative disorders

Stern, M., & McNew, J. A. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00943-9 · Cited by 33 · see citing works

D1R- and D2R-Medium-Sized Spiny Neurons Diversity: Insights Into Striatal Vulnerability to Huntington’s Disease Mutation

Bergonzoni, G., Döring, J., & Biagioli, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.628010 · Cited by 32 · see citing works

Zebrafish an experimental model of Huntington’s disease: molecular aspects, therapeutic targets and current challenges

Kumar, V., Singh, C., & Singh, A. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06787-y · Cited by 32 · see citing works

Interweaving of reactive oxygen species and major neurological and psychiatric disorders

Umare, M. D., Wankhede, N. L., Bajaj, K. K., Trivedi, R. V., Taksande, B. G., Umekar, M. J., Mahore, J., & Kale, M. B. (2021) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2021.11.004 · Cited by 33 · see citing works

Towards a comprehensive understanding of the contributions of mitochondrial dysfunction and oxidative stress in the pathogenesis and pathophysiology of Huntington's disease

Tobore, T. O. (2019) · Journal of Neuroscience Research · doi:10.1002/jnr.24492 · Cited by 32 · see citing works

Gut Bacteria Regulate the Pathogenesis of Huntington’s Disease in Drosophila Model

Chongtham, A., Yoo, J. H., Chin, T. M., Akingbesote, N. D., Huda, A., Marsh, J., & Khoshnan, A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.902205 · Cited by 31 · see citing works

Fibroblast growth factor 9 activates anti-oxidative functions of Nrf2 through ERK signalling in striatal cell models of Huntington's disease

Yusuf, I. O., Chen, H.-M., Cheng, P., Chang, C. S., Tsai, S., Chuang, J., Wu, C., Huang, B., Sun, H. S., & Yang, S. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.455 · Cited by 30 · see citing works

ROS Chronicles in HIV Infection: Genesis of Oxidative Stress, Associated Pathologies, and Therapeutic Strategies

Harshithkumar, R., Shah, P., Jadaun, P., & Mukherjee, A. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46080523 · Cited by 29 · see citing works

Extracellular miRNAs in redox signaling: Health, disease and potential therapies

Ruiz, G. P., Camara, H., Fazolini, N. P. B., & Mori, M. A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.004 · Cited by 29 · see citing works

Nano-bioengineered sensing technologies for real-time monitoring of reactive oxygen species in in vitro and in vivo models

Kumari, R., Dkhar, D. S., Mahapatra, S., divya, D. D., Kumar, R., & Chandra, P. (2022) · Microchemical Journal · doi:10.1016/j.microc.2022.107615 · Cited by 29 · see citing works

Neuroprotective effects ofFoeniculum vulgareseeds extract on lead-induced neurotoxicity in mice brain

Bhatti, S., Shah, S. A. A., Ahmed, T., & Zahid, S. (2018) · Drug and Chemical Toxicology · doi:10.1080/01480545.2018.1459669 · Cited by 29 · see citing works

Exploring molecular mechanisms, therapeutic strategies, and clinical manifestations of Huntington’s disease

Shafie, A., Ashour, A. A., Anwar, S., Anjum, F., & Hassan, M. I. (2024) · Archives of Pharmacal Research · doi:10.1007/s12272-024-01499-w · Cited by 29 · see citing works

Functional foods and bioactive compounds: Roles in the prevention, treatment and management of neurodegenerative diseases

Teibo, J. O., Samuel, B., Olagunju, A. S., Olorunfemi, F. G., Oyetooke, A., & Oluwatosin, F. (2020) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2020.11.2.0143 · Cited by 28 · see citing works

Nrf2-Independent Anti-Inflammatory Effects of Dimethyl Fumarate: Challenges and Prospects in Developing Electrophilic Nrf2 Activators for Neurodegenerative Diseases

Izumi, Y., & Kōyama, Y. (2024) · Antioxidants · doi:10.3390/antiox13121527 · Cited by 27 · see citing works

Study insights in the role of PGC-1α in neurological diseases: mechanisms and therapeutic potential

Tang, M.-B., Liu, Y.-X., Hu, Z., Luo, H.-Y., Zhang, S., Shi, C.-H., & Xu, Y.-M. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1454735 · Cited by 29 · see citing works

Mechanistic Insights and Therapeutic Potential of Quercetin in Neuroprotection: A Comprehensive Review of Pathways and Clinical Perspectives

Debnath, I., Ghosh, S., Jha, S. K., Bhunia, S., Nayak, A., Basak, S., Nandi, S., & Bhattacharjee, S. (2025) · BIO Integration · doi:10.15212/bioi-2025-0073 · Cited by 30 · see citing works

Juvenile Huntington’s Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein

Aladdin, A., Király, R., Botó, P., Regdon, Z., & Tar, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215338 · Cited by 27 · see citing works

Brain microvascular endothelial cell dysfunction in an isogenic juvenile iPSC model of Huntington’s disease

Linville, R. M., Nerenberg, R. F., Grifno, G. N., Arevalo, D., Guo, Z., & Searson, P. C. (2022) · Fluids and Barriers of the CNS · doi:10.1186/s12987-022-00347-7 · Cited by 27 · see citing works

Multifunctional Carbon Quantum Dots Prevent Soluble-to-Toxic Transformation of Amyloid and Oxidative Stress

Ahlawat, J., & Narayan, M. (2022) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.1c08638 · Cited by 26 · see citing works

New Insights into Molecular Mechanisms Underlying Neurodegenerative Disorders

Liu, J., Duan, W., Deng, Y., Zhang, Q., Li, R., Long, J., Waqas, A., Gu, C., Qiu, Y., Cai, H., et al. (2023) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2203058 · Cited by 26 · see citing works

Beyond oxidative stress: Ferroptosis as a novel orchestrator in neurodegenerative disorders

Yi, Y., Jia, P., Xie, P., Peng, X., Zhu, X., Yin, S., Luo, Y., Deng, Y., & Wan, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1683876 · Cited by 28 · see citing works

Integrated multi-omics analysis of Huntington disease identifies pathways that modulate protein aggregation

Pradhan, S. S., Manohar, T. S., Saiswaroop, R., Bhagavatham, S. K. S., Pulukool, S. K., Rathnakumar, S., Kanikaram, S. P., Dandamudi, R. B., Pargaonkar, A., Joseph, P., et al. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049492 · Cited by 25 · see citing works

Applying stem cell therapy in intractable diseases: a narrative review of decades of progress and challenges

Brianna, B., Ling, A. P. K., & Wong, Y. P. (2022) · Stem Cell Investigation · doi:10.21037/sci-2022-021 · Cited by 24 · see citing works

Peroxisom proliferator-activated receptor-γ coactivator-1α in neurodegenerative disorders: A promising therapeutic target

Yang, Y.-N., Zhang, M.-Q., Yu, F.-L., Han, B., Bao, M.-Y., Yan-He, Yan-he, & Zhang, Y. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115717 · Cited by 25 · see citing works

Neuroinflammation and neurodegeneration in Huntington’s disease: genetic hallmarks, role of metals and organophosphates

Kuwar, O. K., & Singh, S. (2025) · Neurogenetics · doi:10.1007/s10048-025-00801-2 · Cited by 24 · see citing works

Blood Oxidative Stress Marker Aberrations in Patients with Huntington’s Disease: A Meta-Analysis Study

Tang, Q., Liu, H., Shi, X., & Cheng, Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9187195 · Cited by 25 · see citing works

Elucidating the Multi-Targeted Role of Nutraceuticals: A Complementary Therapy to Starve Neurodegenerative Diseases

Behl, T., Kaur, G., Sehgal, A., Singh, S., Bhatia, S., Al‐Harrasi, A., Zengin, G., BUNGAU, S. G., Munteanu, M. A., Brisc, M. C., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084045 · Cited by 24 · see citing works

Myelin Lipid Alterations in Neurodegenerative Diseases: Landscape and Pathogenic Implications

Xu, Z., He, S., Begum, M. M., & Han, X. (2024) · Antioxidants and Redox Signaling · doi:10.1089/ars.2024.0676 · Cited by 22 · see citing works

Therapeutic targeting of the oxidative stress generated by pathological molecular pathways in the neurodegenerative diseases, ALS and Huntington's

Bajpai, A., Bharathi, V., & Patel, B. K. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177187 · Cited by 22 · see citing works

Effects of Panthenol and N-Acetylcysteine on Changes in the Redox State of Brain Mitochondria under Oxidative Stress In Vitro

Semenovich, D. S., Plotnikov, E. Y., Titko, O. V., Лукиенко, Е. П., & Kanunnikova, N. P. (2021) · Antioxidants · doi:10.3390/antiox10111699 · Cited by 22 · see citing works

Ferroptosis and cognitive impairment: Unraveling the link and potential therapeutic targets

Naderi, S., Khodagholi, F., Janahmadi, M., Motamedi, F., Torabi, A., Batool, Z., Heydarabadi, M. F., & Pourbadie, H. G. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110210 · Cited by 22 · see citing works

Impaired Redox Signaling in Huntington’s Disease: Therapeutic Implications

Paul, B. D., & Snyder, S. H. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00068 · Cited by 75 · see citing works

A Mitochondria-Associated Oxidative Stress Perspective on Huntington’s Disease

Zheng, J., Winderickx, J., Franssens, V., & Liu, B. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00329 · Cited by 119 · see citing works

Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington’s Disease

D’Egidio, F., Castelli, V., Cimini, A., & d’Angelo, M. (2023) · Antioxidants · doi:10.3390/antiox12030571 · Cited by 41 · see citing works

Oxidative Stress in Huntington’s Disease

Jiménez‐Jiménez, F. J., Alonso‐Navarro, H., García‐Martín, E., Cárcamo-Fonfría, A., Caballero-Muñoz, M. D. M., & Agúndez, J. A. G. (2025) · Biomolecules · doi:10.3390/biom15040527 · Cited by 12 · see citing works

Oxidative stress in primary porcine fibroblasts expressing mutated huntingtin

Šmatlíková, P., Askeland, G., Vaškovičová, M. (., Klíma, J. (., Motlík, J. (., Eide, L., & Ellederová, Z. (. (2017) · ASEP